Q-omics provides the consensus-scored TUBG1P profile across patient tissues and cancer cell-line models. TUBG1P expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, TUBG1P is differentially expressed in 10, with the highest sampling consensus in COAD. Additionally, TUBG1P RNA expression shows 17,681 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight MESO, COAD, and UVM as cancer lineages where TUBG1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TUBG1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TUBG1P survival associations across molecular data types. TUBG1P RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TUBG1P RNA expression–survival associations across cancer types. High TUBG1P expression shows unfavorable associations in MESO, LIHC and UVM, but favorable associations in BLCA, BRCA and PAAD. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for TUBG1P RNA expression.
This table summarizes TUBG1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for TUBG1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TUBG1P shows lower tumor expression in THCA and higher tumor expression in COAD, LIHC, STAD, LUSC and READ. The COAD box plot shows higher TUBG1P RNA expression in tumor versus normal tissue (log2 FC = +0.267, t-test p < 0.001).
This table shows molecular features associated with TUBG1P in patient tissues and cancer cell lines. In patient samples, TUBG1P shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
